Falchi, L., J. M. Baron, C. A. Orlikowski, and A. Ferrajoli. “BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA”. Mediterranean Journal of Hematology and Infectious Diseases, Vol. 8, Feb. 2016, p. e2016011, doi:10.4084/mjhid.2016.011.